Onco-Innovations Limited
ONNVF
$1.10
-$0.22-16.67%
OTC PK
| 07/31/2025 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 340.97% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 449.26% | ||||
| Operating Income | -436.19% | ||||
| Income Before Tax | -734.10% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -734.10% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -734.10% | ||||
| EBIT | -436.19% | ||||
| EBITDA | -- | ||||
| EPS Basic | -433.33% | ||||
| Normalized Basic EPS | -945.45% | ||||
| EPS Diluted | -433.33% | ||||
| Normalized Diluted EPS | -945.45% | ||||
| Average Basic Shares Outstanding | 56.27% | ||||
| Average Diluted Shares Outstanding | 56.27% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||